Skip to main content
. 2012 Oct 16;8(5):841–847. doi: 10.5114/aoms.2012.31133

Figure 3.

Figure 3

Yearly increases in BMD (mean ± SD) in FHA patients subjected to 4-year EP treatment (group A) stratified depending on haplotypes of ER-α